U.S. Electrical Stock News

NasdaqGS:HURN
NasdaqGS:HURNProfessional Services

Huron Consulting Group (HURN) Margins Lag Bullish Narrative Despite Q1 2026 Revenue Growth

Huron Consulting Group (HURN) opened 2026 with Q1 revenue of US$451.8 million and basic EPS of US$1.37, set against trailing twelve month revenue of about US$1.7 billion and EPS of US$6.02 as investors weigh how the latest quarter fits into the broader earnings trend. The company has seen quarterly revenue move from US$395.7 million in Q1 2025 to US$451.8 million in Q1 2026, while quarterly EPS tracked from US$1.38 to US$1.37 over the same period, leaving the headline numbers solid and...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet EVOLVE Trial Targets Type 2 Market As Shares Trade Below Targets

Insulet (NasdaqGS:PODD) has begun its pivotal EVOLVE study of a fully closed loop automated insulin delivery system for people with type 2 diabetes. The first participant has been enrolled, marking an important step in testing this technology beyond the company’s existing Omnipod 5 offering. The study focuses on expanding automated insulin delivery to a large and currently underserved segment of the diabetes population. For investors watching Insulet at a share price of $151.28, the EVOLVE...
NasdaqGM:WLFC
NasdaqGM:WLFCTrade Distributors

Is It Too Late To Consider Willis Lease Finance (WLFC) After Its Recent Share Price Surge?

If you are wondering whether Willis Lease Finance at around US$229 per share still offers value, you are not alone in asking what the current price really reflects. The stock has recently posted returns of 19.6% over 7 days, 30.2% over 30 days, 70.8% year to date and 72.3% over 1 year, with very large gains over 3 and 5 years. Recent headlines have focused on Willis Lease Finance within the capital goods and aircraft leasing space, highlighting how investors are paying closer attention to...
NasdaqGS:EWTX
NasdaqGS:EWTXPharmaceuticals

Why Edgewise Therapeutics (EWTX) Is Up 21.5% After Positive Trial, FDA Updates And Equity Grants

Edgewise Therapeutics recently reported positive outcomes from drug trials and FDA-related developments, while also granting inducement stock options for 266,000 shares to nine new non-executive employees under its 2024 Inducement Equity Incentive Plan. These clinical updates, combined with a catalyst-rich pipeline and management’s decision to expand the team with equity-linked hires, highlight the company’s focus on executing its late- and mid-stage programs. We’ll now examine how the...
NasdaqGS:TLN
NasdaqGS:TLNRenewable Energy

Talen Energy (TLN) Q1 Profit Of US$63 Million Tests Volatility Concerns

Talen Energy (TLN) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$1.38, alongside trailing 12 month revenue of US$3.4 billion and a small net loss of US$21 million that translates to basic EPS of US$0.46 in the red. Over recent quarters, the company has seen revenue range from US$454 million to US$1.1 billion and basic EPS swing between a loss of US$7.95 and a gain of US$4.53. This sets up a results season where investors will be focused on how consistently those higher...
NYSE:EVC
NYSE:EVCMedia

Entravision Communications (EVC) Returns To Quarterly Profit In Q1 2026 Challenging Bearish Narratives

Entravision Communications (EVC) has opened 2026 with Q1 revenue of US$197.0 million and basic EPS of US$0.13, alongside net income from ongoing operations of US$12.4 million. The company has seen revenue move from US$91.9 million in Q1 2025 and US$107.0 million in Q4 2024 to US$197.0 million in Q1 2026. EPS has shifted from losses of US$0.53 and US$0.62 in those respective quarters to a profit in the latest period, setting up a quarter where investors will be focused on how durable these...
NYSE:BBAI
NYSE:BBAIIT

BigBear.ai Holdings (BBAI) Q1 Loss Of US$56.8 Million Reinforces Bearish Profitability Narrative

BigBear.ai Holdings (BBAI) opened Q1 2026 with revenue of about US$34.4 million and a basic EPS loss of roughly US$0.12, setting the tone for another quarter where growth and profitability are pulling in different directions. Over recent periods, revenue has moved between US$27.3 million and US$43.8 million a quarter, while basic EPS has ranged from a small profit of about US$0.01 to a loss of roughly US$0.71, underscoring how volatile margins have been as the business scales. In that...
NasdaqGS:ANGI
NasdaqGS:ANGIInteractive Media and Services

Angi (ANGI) Margin Improvement Supports Bullish Profitability Narrative Despite Modest FY 2025 Revenue

Angi (ANGI) posts FY 2025 results with steady profitability and modest top line Angi (ANGI) closed FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.17, while trailing twelve month EPS reached US$0.96 on net income of US$43.8 million, setting a clear reference point for the year at a share price of US$7.41. Over the past six reported quarters, revenue has ranged from US$240.8 million to US$296.7 million, while quarterly basic EPS has moved between a loss of US$0.03...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

A Look At Phathom Pharmaceuticals (PHAT) Valuation After Narrower Losses And Reaffirmed Profitability Timeline

Phathom Pharmaceuticals (PHAT) recently reported first quarter results showing a net loss of US$30.37 million, alongside reaffirmed 2026 guidance that includes an operating profitability target beginning in the third quarter. See our latest analysis for Phathom Pharmaceuticals. The stock’s recent 12.62% 1 month share price return, alongside a 7.56% 7 day gain, contrasts with a 19.35% year to date share price decline. At the same time, the 1 year total shareholder return above 400% highlights...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Q1 EPS Surge Tests Bullish Margin Narrative

Hecla Mining (HL) earnings snapshot Hecla Mining (HL) has put fresh numbers on the table for Q1 2026, with revenue of US$411.4 million, basic EPS of US$0.25 and net income from continuing operations of US$164.5 million, while also reporting earnings from discontinued operations of US$183.7 million. Over the past year, the company has seen revenue move from US$929.9 million on a trailing basis to US$1.57 billion and EPS shift from US$0.06 to US$0.69, alongside a very large year over year...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group (LCID) Q4 Loss Of US$1.18b Tests Bullish Margin Improvement Narrative

Lucid Group (LCID) has just wrapped up FY 2025 with fourth quarter revenue of US$522.7 million, a basic EPS loss of US$3.62, and net income loss of US$1.18 billion. The trailing twelve month figures show revenue of US$1.35 billion and a basic EPS loss of US$11.81. The company’s revenue has moved from US$807.8 million on a trailing basis at the end of 2024 to US$1.35 billion by the end of 2025. EPS has remained deeply negative over the same stretch, setting up a results season in which...
NYSE:AIZ
NYSE:AIZInsurance

Assurant (AIZ) Q1 EPS Beat Strength Narrative Of Margin Stability And Earnings Quality

Assurant (AIZ) kicked off 2026 with Q1 revenue of US$3.4 billion and basic EPS of US$5.51, alongside net income excluding extra items of US$274.1 million, setting a clear marker for how the year is starting to shape up. Over recent quarters the company has seen revenue move from US$3.1 billion in Q1 2025 to US$3.4 billion in Q1 2026. Basic EPS has ranged between US$2.86 and US$5.23 in 2025 before reaching US$5.51 this quarter, giving you a clear view of how the income line has been tracking...
NYSE:JXN
NYSE:JXNDiversified Financial

Jackson Financial Q1 EPS Loss Deepens Challenging Bullish Margin Narratives

Jackson Financial's Q1 2026 Numbers Set the Stage for a Margin Story Jackson Financial (JXN) has opened 2026 with Q1 revenue of about US$2.9 billion and a basic EPS loss of US$6.24, alongside a trailing twelve month EPS loss of US$5.94 and net income loss of US$417 million. The company has seen quarterly revenue range from US$245 million in Q4 2024 to US$3.8 billion in Q1 2025. Basic EPS has swung between a profit of US$4.50 in Q4 2024 and the current Q1 2026 loss, which puts investor...
NasdaqGS:AZTA
NasdaqGS:AZTALife Sciences

Azenta (AZTA) Quarterly Loss Of US$157 Million Reinforces Bearish Margin Narratives

Azenta (AZTA) has put a tough quarter on the table, with Q2 2026 revenue of US$144.8 million and a basic EPS loss of US$3.41, alongside net income from continuing operations showing a loss of US$157.0 million. The company has seen quarterly revenue move from US$143.4 million in Q2 2025 to US$158.0 million in Q4 2025 and then to US$144.8 million in Q2 2026. EPS has swung from a loss of US$0.40 in Q2 2025 to a profit of US$1.12 in Q4 2025 and back to a loss of US$3.41 in the latest quarter,...
NasdaqGS:RIGL
NasdaqGS:RIGLBiotechs

Rigel Pharmaceuticals (RIGL) Q1 EPS Compression Tests Bullish High‑Earnings Narrative

Rigel Pharmaceuticals (RIGL) opened 2026 with Q1 revenue of US$58.8 million and basic EPS of US$0.47, alongside trailing 12‑month revenue of US$299.8 million and basic EPS of US$20.08, set against very large year over year earnings growth and higher net profit margins in the latest trailing figures. Over recent quarters the company has seen revenue move from US$57.6 million in Q4 2024 to US$53.3 million in Q1 2025, US$101.7 million in Q2 2025, US$69.5 million in Q3 2025 and US$69.8 million in...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Duolingo (DUOL) Q1 Margin Strength Tests Bullish Profit Sustainability Narratives

Q1 2026 earnings snapshot Duolingo (DUOL) opened 2026 with Q1 revenue of US$292.0 million and basic EPS of US$0.93, setting the tone for the latest results at a share price of US$105.02. Over the past year, the company has seen revenue move from US$230.7 million in Q1 2025 to US$292.0 million in Q1 2026, while basic EPS shifted from US$0.78 to US$0.93, against a trailing twelve month EPS figure of US$9.14. With trailing net profit margins now framed by a much higher earnings base, the story...
NYSE:MCY
NYSE:MCYInsurance

Mercury General (MCY) Wildfire Combined Ratio Swings Challenge Underwriting Stability Narratives

Mercury General (MCY) closed out FY 2025 with Q4 revenue of US$1.5 billion and basic EPS of US$3.66, supported by trailing twelve month revenue of US$6.0 billion and EPS of US$9.77. Over the past few quarters, revenue has moved from US$1.39 billion in Q1 2025 to US$1.54 billion in Q4 2025, while quarterly EPS has ranged from a loss of US$1.96 in Q1 2025 to a high of US$5.06 in Q3 2025. These figures provide context for investors assessing recent net income of US$202.5 million alongside a more...
NYSE:STWD
NYSE:STWDMortgage REITs

What Starwood Property Trust (STWD)'s FIP Acquisition and Dilution Concerns Mean For Shareholders

In recent days, analyst reports from JPMorgan and BofA Securities reassessed Starwood Property Trust following its Fundamental Income Partners acquisition and ongoing sector headwinds in commercial real estate finance. While highlighting higher interest rates and potential dilution as near-term challenges, the commentary also underscored that Starwood’s lending pipeline and capital deployment activity remain meaningfully engaged, keeping institutional attention on the REIT. Next, we’ll...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos Holdings (LDOS) Net Margin Near 8.2% Tests Slower Earnings Growth Narratives

Leidos Holdings (LDOS) opened 2026 with Q1 revenue of US$4.4b and basic EPS of US$2.60, alongside trailing 12 month revenue of US$17.3b and EPS of US$11.13 that sit against a 8.2% net margin, up from 7.9% a year earlier. Over the past year, earnings growth of 6.1% has run below the five year average of 18.1%. This puts more weight on how investors read the balance between steady profit generation and the current margin profile. Overall, the latest numbers point to a business where...
NasdaqCM:NUTX
NasdaqCM:NUTXHealthcare

Nutex Health (NUTX) Is Up 5.1% After Strong Q1 Results And New Buyback Plan - What's Changed

Nutex Health reported past first-quarter 2026 results on April 30, with revenue of US$216.49 million and net income of US$46.81 million, lifting both basic and diluted earnings per share from continuing operations versus a year earlier. Alongside these results, the company announced a second US$25.00 million share repurchase program and a shift toward directly developing new hospital facilities, signaling a material change in how it funds and expands its footprint. We’ll now examine how...
NYSE:AU
NYSE:AUMetals and Mining

Is It Too Late To Consider AngloGold Ashanti (NYSE:AU) After 136% One Year Surge?

Wondering whether AngloGold Ashanti at around US$98.60 is still offering value after a strong run, or if most of the easy gains are already behind it. The stock has been volatile recently, with a 9.0% return over the last 7 days, a 2.8% decline over 30 days, a 15.2% return year to date, and a 136.0% return over the last year, alongside very large multi year gains of around 3x over 3 years and nearly 4x over 5 years. Recent coverage has focused on AngloGold Ashanti's position within the...
NYSE:FERG
NYSE:FERGTrade Distributors

Ferguson (FERG) Q1 2026 Margin Gains Test Bullish Earnings Narratives

Ferguson Enterprises Q1 2026 headline numbers Ferguson Enterprises (FERG) opened fiscal Q1 2026 with revenue of about US$7.5b and basic EPS of US$2.13, setting a clear marker for how the business is starting the new financial year. The company has seen quarterly revenue move from roughly US$7.2b in Q1 2025 to about US$7.5b in Q4 2025 and then US$7.5b in Q1 2026. Basic EPS has shifted from US$1.74 to US$1.99 and then US$2.13 over the same periods, giving investors a view on how earnings are...
NYSE:JBTM
NYSE:JBTMMachinery

JBT Marel (JBTM) Quarterly Profit Of US$53.1m Tests Bearish Loss-Narrative

JBT Marel (JBTM) has just put fresh numbers on the table for Q1 2026, coming off Q4 2025 revenue of about US$1.0 billion and basic EPS of US$1.02, against a trailing twelve month picture that includes a basic EPS loss of US$0.96 on US$3.8 billion of revenue. Over the past few quarters, the company has seen quarterly revenue move from US$453.8 million in Q3 2024 to US$854.1 million in Q1 2025 and then to roughly US$1.0 billion by Q4 2025. EPS swung from US$1.19 in Q3 2024 to a loss of US$3.35...
NYSE:NRG
NYSE:NRGElectric Utilities

Is It Time To Revisit NRG Energy (NRG) After Its Strong Five Year Share Price Gain

With NRG Energy last closing at US$150.64, this article looks at whether the stock is still priced for opportunity or already reflects most of its story, and what that may mean for you as an investor. The stock has returned 1.1% over the last 7 days and 0.6% over the last 30 days, with a year-to-date decline of 9.3% and a 28.4% return over the last year, alongside a very large gain over 5 years. Recent coverage has focused on NRG Energy's position within the US utilities sector and how its...